Lipid droplets provide metabolic flexibility for cancer progression
FEBS Letters · 2024-05 · 598 (10) · 1301-1327
DOI: 10.1002/1873-3468.14820 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift FEBS Letters, online erschienen am 07.02.2024. Verfasst von Rémi Safi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Josep Carreras Leukemia Research Institute, Barcelona, Spain. Hauptthemen laut MEDLINE: Lipid Droplets, Neoplasms, Disease Progression. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 274 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Lady Tata memorial Trust Grant, German Josep Carreras Leukemia Stiftung, Spanish Ministry of Science and Innovation (MINECO).
Abstract (Originalsprache)
A hallmark of cancer cells is their remarkable ability to efficiently adapt to favorable and hostile environments. Due to a unique metabolic flexibility, tumor cells can grow even in the absence of extracellular nutrients or in stressful scenarios. To achieve this, cancer cells need large amounts of lipids to build membranes, synthesize lipid‐derived molecules, and generate metabolic energy in the absence of other nutrients. Tumor cells potentiate strategies to obtain lipids from other cells, metabolic pathways to synthesize new lipids, and mechanisms for efficient storage, mobilization, and utilization of these lipids. Lipid droplets (LDs) are the organelles that collect and supply lipids in eukaryotes and it is increasingly recognized that the accumulation of LDs is a new hallmark of cancer cells. Furthermore, an active role of LD proteins in processes underlying tumorigenesis has been proposed. Here, by focusing on three major classes of LD‐resident proteins (perilipins, lipases, and acyl‐CoA synthetases), we provide an overview of the contribution of LDs to cancer progression and discuss the role of LD proteins during the proliferation, invasion, metastasis, apoptosis, and stemness of cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Josep Carreras Leukemia Research Institute, Barcelona, Spain.
- Lipid Trafficking and Disease Group, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.
- Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
- Department of Biomedical Sciences, Faculty of Medicine, Universitat de Barcelona, Spain.
- Consorcio Investigación Biomédica en Red de Cancer, CIBER-ONC, ISCIII, Barcelona, Spain.
- Spanish Network for Advanced Cell Therapies (TERAV), Barcelona, Spain.
ORCID-Profile: Albert Pol
Förderung
- Lady Tata memorial Trust Grant
- German Josep Carreras Leukemia Stiftung
- Spanish Ministry of Science and Innovation (MINECO)
- H2020-MSCA-ITN-2018
- Marie Skłodowska-Curie Actions Postdoctoral Fellowship (MSCA-PF)
- I+D+i RETOS INVESTIGACIÓN
- ERC Synergy Grant
- sameasI+D+iRETOSINVESTIGACIÓN
Zitieren
APA
Safi, R., Menéndez, P., & Pol, A. (2024). Lipid droplets provide metabolic flexibility for cancer progression. FEBS Letters, 598(10), 1301-1327. https://doi.org/10.1002/1873-3468.14820
Vancouver
Safi R, Menéndez P, Pol A. Lipid droplets provide metabolic flexibility for cancer progression. FEBS Letters. 2024;598(10):1301-1327. doi:10.1002/1873-3468.14820
BibTeX
@article{Safi2024,
author = {Safi, Rémi and Menéndez, Pablo and Pol, Albert},
title = {Lipid droplets provide metabolic flexibility for cancer progression},
journal = {FEBS Letters},
year = {2024},
volume = {598},
number = {10},
pages = {1301--1327},
doi = {10.1002/1873-3468.14820}
}
EUVIMED